Published in J Neuroimmunol on August 01, 1991
Immunotherapeutic approaches for glioma. Crit Rev Immunol (2009) 1.55
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem (2005) 1.09
Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol (2010) 1.05
Immune Evasion Strategies of Glioblastoma. Front Surg (2016) 0.88
Immunotherapy for solid tumors--a review for surgeons. J Surg Res (2013) 0.83
U87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissues. Oncol Lett (2013) 0.79
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14
Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery (1995) 3.10
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
The development of anatomic art and sciences: the ceroplastica anatomic models of La Specola. Neurosurgery (1999) 1.78
Definition of the role of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurgery (1991) 1.77
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Third ventricular cysticercal cyst mimicking a colloid cyst: case report. Neurosurgery (1995) 1.62
Computed tomographic guidance stereotaxis in the management of intracranial mass lesions. Neurosurgery (1983) 1.60
Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res (1998) 1.59
Vagus nerve stimulation activates central nervous system structures in epileptic patients during PET H2(15)O blood flow imaging. Neurosurgery (1996) 1.57
Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol (1991) 1.54
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery (1987) 1.50
Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg (1990) 1.46
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43
Transcallosal, interfornicial approaches for lesions affecting the third ventricle: surgical considerations and consequences. Neurosurgery (1982) 1.42
Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology (1992) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
Surgical considerations in treatment of intraventricular cysticercosis. An analysis of 45 cases. J Neurosurg (1984) 1.41
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
Glial cell influence on the human blood-brain barrier. Glia (2001) 1.36
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
High dose glucocorticoids in the management of severe head injury. Neurosurgery (1984) 1.27
Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A (1991) 1.27
MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol (1998) 1.26
Computed tomographic guidance stereotaxis in the management of lesions of the third ventricular region. Neurosurgery (1984) 1.26
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol (1992) 1.24
Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl J Med (1984) 1.23
Preliminary experience with Brown-Roberts-Wells (BRW) computerized tomography stereotaxic guidance system. J Neurosurg (1983) 1.21
Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J Neuropathol Exp Neurol (2001) 1.20
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
Transoral exposure of the atlantoaxial region. Neurosurgery (1978) 1.19
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology (1994) 1.18
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain (1999) 1.17
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia (2007) 1.16
Acute fractures of the odontoid process. An analysis of 45 cases. J Neurosurg (1978) 1.16
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
Neurosurgical endoscopy using the side-viewing telescope. J Neurosurg (1977) 1.14
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri. Am J Ophthalmol (1981) 1.12
Interstitial radiobrachytherapy of malignant cerebral neoplasms: rationale, methodology, prospects. Neurol Res (1987) 1.12
Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res (1996) 1.11
CNS microvascular pericytes express macrophage-like function, cell surface integrin alpha M, and macrophage marker ED-2. Microvasc Res (1996) 1.10
Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery (1999) 1.10
Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery (1989) 1.09
Inhibition of medulloblastoma cell invasion by Slit. Oncogene (2006) 1.09
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
A phantom study of the geometric accuracy of computed tomographic and magnetic resonance imaging stereotactic localization with the Leksell stereotactic system. Neurosurgery (2001) 1.08
Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res (1999) 1.08
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol (1998) 1.08
Management of cervical spinal cord trauma in Southern California. J Neurosurg (1975) 1.06
Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J Neurosurg (1984) 1.05
Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol (1995) 1.04
Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system. Neurosurgery (1997) 1.04
A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol (1995) 1.04
Cystic fluid in craniopharyngiomas: MR imaging and quantitative analysis. Radiology (1992) 1.04
B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol (1994) 1.03
Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest (1996) 1.02
IL-10 production by adult human derived microglial cells. Neurochem Int (1996) 1.02
Pineal apoplexy associated with anticoagulant therapy. Case report. J Neurosurg (1976) 1.02
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol (1994) 1.01
Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery (2000) 1.01
The significance of subarachnoid hemorrhage after penetrating craniocerebral injury: correlations with angiography and outcome in a civilian population. Neurosurgery (1993) 1.00
Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol (1996) 1.00
Multiple meningiomas following radiation therapy for medulloblastoma. Case report. J Neurosurg (1981) 1.00
Linkage analysis in familial amyotrophic lateral sclerosis. Neurology (1989) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
Role of stereotactic biopsy in the diagnosis and management of brain tumors. Semin Surg Oncol (1998) 0.99
Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg (1988) 0.99
Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci (1995) 0.98
CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol (2000) 0.98
Stereotactic radiosurgery: principles and comparison of treatment methods. Neurosurgery (1993) 0.98
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery (1991) 0.97
Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol (2000) 0.96
Ionizing and nonionizing radiation treatment of malignant cerebral gliomas: specialized approaches. Clin Neurosurg (1983) 0.96
Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology (2000) 0.95
Thoracic spinal angiomyolipoma: case report and literature review. Neurosurgery (1985) 0.95
An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome. Neurosurgery (1998) 0.95
Penetrating gunshot wounds of the cervical spine in civilians. Review of 38 cases. J Neurosurg (1975) 0.94
Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol (1982) 0.94
Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol (2000) 0.93
Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann Neurol (1999) 0.93
T cell regulation of polyclonally induced immunoglobulin secretion in humans. J Immunol (1984) 0.93
p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci (1998) 0.93
Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J Immunol (1999) 0.92
NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol (2001) 0.92
Immunohistochemical studies of adult human glial cells. J Neuroimmunol (1989) 0.92